久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/24 | 3,935 | 3,985 | 3,915 | 3,955 | +35 | +0.9% | 128,900 |
| 2023/01/23 | 3,900 | 3,965 | 3,875 | 3,920 | +60 | +1.6% | 173,500 |
| 2023/01/20 | 3,830 | 3,895 | 3,820 | 3,860 | +35 | +0.9% | 142,000 |
| 2023/01/19 | 3,860 | 3,880 | 3,815 | 3,825 | -90 | -2.3% | 165,900 |
| 2023/01/18 | 3,850 | 3,915 | 3,820 | 3,915 | +55 | +1.4% | 201,000 |
| 2023/01/17 | 3,810 | 3,885 | 3,795 | 3,860 | +55 | +1.4% | 165,100 |
| 2023/01/16 | 3,825 | 3,830 | 3,735 | 3,805 | -65 | -1.7% | 210,100 |
| 2023/01/13 | 3,735 | 3,890 | 3,725 | 3,870 | +190 | +5.2% | 429,400 |
| 2023/01/12 | 3,665 | 3,705 | 3,660 | 3,680 | +15 | +0.4% | 167,100 |
| 2023/01/11 | 3,645 | 3,700 | 3,640 | 3,665 | +20 | +0.5% | 145,500 |
| 2023/01/10 | 3,655 | 3,675 | 3,620 | 3,645 | +5 | +0.1% | 181,300 |
| 2023/01/06 | 3,670 | 3,685 | 3,635 | 3,640 | -50 | -1.4% | 147,600 |
| 2023/01/05 | 3,725 | 3,735 | 3,690 | 3,690 | -50 | -1.3% | 121,800 |
| 2023/01/04 | 3,915 | 3,915 | 3,740 | 3,740 | -185 | -4.7% | 187,300 |
| 2022/12/30 | 3,915 | 3,965 | 3,915 | 3,925 | +10 | +0.3% | 120,700 |
| 2022/12/29 | 3,900 | 3,915 | 3,880 | 3,915 | +20 | +0.5% | 111,200 |
| 2022/12/28 | 3,850 | 3,915 | 3,835 | 3,895 | +35 | +0.9% | 106,000 |
| 2022/12/27 | 3,855 | 3,900 | 3,855 | 3,860 | +20 | +0.5% | 98,000 |
| 2022/12/26 | 3,820 | 3,840 | 3,805 | 3,840 | +40 | +1.1% | 114,100 |
| 2022/12/23 | 3,795 | 3,820 | 3,780 | 3,800 | ±0 | ±0% | 100,600 |
| 2022/12/22 | 3,795 | 3,820 | 3,755 | 3,800 | +5 | +0.1% | 112,400 |
| 2022/12/21 | 3,765 | 3,845 | 3,735 | 3,795 | +10 | +0.3% | 169,700 |
| 2022/12/20 | 3,795 | 3,855 | 3,775 | 3,785 | -5 | -0.1% | 206,600 |
| 2022/12/19 | 3,820 | 3,850 | 3,790 | 3,790 | -50 | -1.3% | 123,100 |
| 2022/12/16 | 3,880 | 3,895 | 3,835 | 3,840 | -40 | -1% | 278,700 |
| 2022/12/15 | 3,870 | 3,910 | 3,860 | 3,880 | ±0 | ±0% | 102,400 |
| 2022/12/14 | 3,895 | 3,930 | 3,875 | 3,880 | ±0 | ±0% | 115,100 |
| 2022/12/13 | 3,860 | 3,895 | 3,860 | 3,880 | +20 | +0.5% | 134,000 |
| 2022/12/12 | 3,845 | 3,875 | 3,825 | 3,860 | ±0 | ±0% | 163,000 |
| 2022/12/09 | 3,790 | 3,860 | 3,790 | 3,860 | +70 | +1.8% | 154,100 |
| 2022/12/08 | 3,795 | 3,820 | 3,785 | 3,790 | -5 | -0.1% | 122,000 |
| 2022/12/07 | 3,760 | 3,830 | 3,750 | 3,795 | +15 | +0.4% | 127,000 |
| 2022/12/06 | 3,745 | 3,800 | 3,745 | 3,780 | +20 | +0.5% | 126,900 |
| 2022/12/05 | 3,765 | 3,765 | 3,700 | 3,760 | -15 | -0.4% | 154,400 |
| 2022/12/02 | 3,820 | 3,820 | 3,755 | 3,775 | -60 | -1.6% | 157,700 |
| 2022/12/01 | 3,870 | 3,875 | 3,805 | 3,835 | -35 | -0.9% | 137,900 |
| 2022/11/30 | 3,865 | 3,885 | 3,850 | 3,870 | -25 | -0.6% | 126,100 |
| 2022/11/29 | 3,895 | 3,925 | 3,870 | 3,895 | -20 | -0.5% | 106,800 |
| 2022/11/28 | 3,925 | 3,935 | 3,880 | 3,915 | +10 | +0.3% | 142,200 |
| 2022/11/25 | 3,960 | 3,960 | 3,890 | 3,905 | -55 | -1.4% | 89,100 |
| 2022/11/24 | 3,945 | 3,970 | 3,930 | 3,960 | +55 | +1.4% | 204,400 |
| 2022/11/22 | 3,860 | 3,920 | 3,860 | 3,905 | +75 | +2% | 202,200 |
| 2022/11/21 | 3,845 | 3,850 | 3,800 | 3,830 | +15 | +0.4% | 169,100 |
| 2022/11/18 | 3,735 | 3,815 | 3,735 | 3,815 | +90 | +2.4% | 231,500 |
| 2022/11/17 | 3,660 | 3,745 | 3,660 | 3,725 | +70 | +1.9% | 154,500 |
| 2022/11/16 | 3,590 | 3,675 | 3,575 | 3,655 | +65 | +1.8% | 180,400 |
| 2022/11/15 | 3,580 | 3,615 | 3,580 | 3,590 | +15 | +0.4% | 122,200 |
| 2022/11/14 | 3,575 | 3,605 | 3,570 | 3,575 | -25 | -0.7% | 135,600 |
| 2022/11/11 | 3,660 | 3,660 | 3,600 | 3,600 | ±0 | ±0% | 126,000 |
| 2022/11/10 | 3,590 | 3,610 | 3,535 | 3,600 | +15 | +0.4% | 135,200 |
601～
650
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 400,200円 | +5.8% | +1.2% | 3.00% | 13.27倍 | 1.06倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ロート | 206,800円 | +8.4% | +0.2% | 2.03% | 15.03倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 89,500円 | -11.0% | +206.6% | 0.00% | 8.89倍 | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 350,300円 | +3.8% | -19.9% | 3.88% | 11.38倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 313,300円 | +8.0% | -15.3% | 3.96% | 8.80倍 | 0.85倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
